Showing results (1-10 of 144) with videos related to
Sort By:
Pageof 15
Journal of Clinical Lipidology|March 14, 2026
ApoA-1 versus HDL-C as markers of cardiovascular riskSelin Bilgic, Karol Pencina, Michael Pencina, et al.Current Opinion in Endocrinology, Diabetes, and Obesity|February 21, 2013
Update on the detection and treatment of atherogenic low-density lipoproteinsAllan Sniderman, Peter O KwiterovichJournal of Biomedical Research|August 16, 2017
Shunts, channels and lipoprotein endosomal traffic: a new model of cholesterol homeostasis in the hepatocyteRobert Scott Kiss, Allan SnidermanCurrent Opinion in Lipidology|April 19, 2021
Update on apolipoprotein BAllan Sniderman, Michel Langlois, Christa CobbaertClinical Chemistry|February 28, 2002
Can measurement of serum apolipoprotein B replace the lipid profile monitoring of patients with lipoprotein disorders?Saman Miremadi, Allan Sniderman, Jiri FrohlichCurrent Atherosclerosis Reports|August 12, 2009
ApoB versus non-HDL-C: what to do when they disagreeAllan Sniderman, Ken Williams, Christa CobbaertNutrition Research Reviews|November 9, 2016
Nutritional management of hyperapoBValérie Lamantia, Allan Sniderman, May FarajNature Reviews. Endocrinology|April 28, 2010
Diagnosis and treatment of apolipoprotein B dyslipoproteinemiasAllan Sniderman, Patrick Couture, Jacqueline de GraafThe American Journal of Cardiology|November 18, 2005
Assessment of reaching goal in patients with combined hyperlipidemia: low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, or apolipoprotein BEvan A Stein, Allan Sniderman, Peter LaskarzewskiPageof 15